Results 201 to 210 of about 84,534 (351)

Targeting the Spinal Cord‐Brain Axis: Electroacupuncture Mitigates Remote Frontal Cortex Neuroinflammation via HMGB1/TLR4 to Aid Functional Recovery After Spinal Cord Injury

open access: yesBrain and Behavior, Volume 16, Issue 1, January 2026.
Spinal cord injury (SCI) has been shown to trigger remote neuroinflammation in the frontal cortex via the HMGB1/TLR4/NF‐κB pathway, exacerbating neural damage and impairing functional recovery. The present study demonstrates that electroacupuncture (EA) at GV4 (Mingmen) and GV14 (Dazhui) effectively mitigates this pathological cascade.
Yu Ning   +9 more
wiley   +1 more source

Efficacy and safety of acupuncture therapy for leukopenia after chemotherapy or radiotherapy: A systematic review and meta-analysis

open access: hybrid
Yunpeng Deng   +9 more
openalex   +1 more source

An Anatomical Consideration on the Safety of a Meridian Point (Danchu, CV17) in Acupuncture Therapy.

open access: bronze, 2000
Tomofumi OZAKI   +9 more
openalex   +2 more sources

Implementation of Electrical Auricular Acupuncture and Low Frequency Modulated Electric Current Therapy in Pain Management of Patients with Knee Osteoarthritis: A Randomized Pilot Trial [PDF]

open access: gold, 2019
Irena Krusche-Mandl   +9 more
openalex   +1 more source

Racial and Ethnic Disparities in Pharmacologic and Non‐Pharmacologic Pain Management Among Older Cancer Survivors

open access: yesCancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Introduction Pain is common among cancer survivors and often managed with medication; however, racial‐ethnic disparities persist in pain treatment. Given inadequate data on pharmacologic and non‐pharmacologic pain management among minoritized cancer survivors, we investigated these patterns using the SEER‐Medicare claims linked database ...
Oindrila Bhattacharyya   +5 more
wiley   +1 more source

Pitolisant Inhibits Alcohol Drinking and Improves Withdrawal Negative Affect Through Lateral Habenula Histaminergic Signaling in Mice

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
Pitolisant, an FDA‐approved H3R antagonist, counteracts the rewarding and sedative effects of ethanol, reduces alcohol intake, and alleviates the negative affect during withdrawal. This might occur via the antagonism of presynaptic autoreceptors and heteroreceptors H3Rs in the lateral habenula, thereby activating the H2R/p‐CREB/BDNF signaling and ...
Yan Zhao   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy